Document is current
Any future updates will be listed below
-
Authors
Nemčko, Filip http://orcid.org/0000-0002-0588-6846
Himmelsbach, Moritz http://orcid.org/0009-0004-4454-7259
Loubiere, Vincent http://orcid.org/0000-0002-3632-378X
Yelagandula, Ramesh http://orcid.org/0000-0001-7418-4322
Pagani, Michaela
Fasching, Nina
Brennecke, Julius http://orcid.org/0000-0002-5141-0814
Elling, Ulrich http://orcid.org/0000-0002-4514-2809
Stark, Alexander http://orcid.org/0000-0003-2611-0841
Ameres, Stefan L. http://orcid.org/0000-0002-8248-3098
- License Information
-
More Information
Article History
Received: 25 September 2023
Accepted: 10 June 2024
First Online: 5 July 2024
Competing interests
: S.L.A. is cofounder, advisor and member of the board of QUANTRO Therapeutics GmbH. U.E. is cofounder of JLP Health and VIVERITA Therapeutics, Managing Director of VIVERITA Discovery and advisor to TANGO Therapeutics. N.F. is employed by QUANTRO Therapeutics GmbH. The other authors declare no competing interests.
